Colorectal cancer mortality trend in Mato Grosso, Brazil, 2000 to 2019

• Autor(a) principal: Carvalho, Alessandra Emídio de
• Data de Publicação: 2022
• Outros Autores: Souza, Rita Adriana Gomes de, Galvão, Noemi Dreyer, Melanda, Francine Nesello, Caló, Romero dos Santos, Souza, Bárbara da Silva Nalin de, Lima, Fernanda Cristina da Silva de, Aguilar, Luisa Bertoldi
• Tipo de documento: preprint
• Idioma: por
• Título da fonte: SciELO Preprints
• Texto Completo: https://preprints.scielo.org/index.php/scielo/preprint/view/3954
• topic: Mortalidade; Neoplasias Colorretais; Epidemiologia; Estudos de Séries Temporais; Mortality; Colorectal Neoplasms; Epidemiology; Time Series Studies.

Objective: To analyze the time series of colorectal cancer (CRC) mortality, according to sex and age group, in Mato Grosso, Brazil, from 2000 to 2019. Methods: Ecological time series study, with standardized mortality rates by CRC (C18 to C21), of residents in Mato Grosso. Information on deaths was provided by the Mato Grosso State Department of Health, and comprise the Mortality Information System, and demographic information obtained from the Brazilian Institute of Geography and Statistics. For the analysis of the temporal trend, the joinpoint regression analysis was used. Results: A total of 2,406 deaths from CRC were identified in Mato Grosso in the period 2000 to 2019. The highest rates were found among the age groups from 60 to 79 years. For men, there was an increasing trend in mortality rates due to CRC for almost all age groups, with the exception of those aged 40 to 49 years and those aged 80 years or more. For women, there was a significant increase in the age groups from 50 to 59 years and 80 years or more. Conclusion: The results of the study showed an increase in mortality rates from CRC in the state of Mato Grosso, from 2000 to 2019, in certain age groups of both sexes, but especially for men. Knowledge about the evolution of mortality can provide data on the epidemiological situation of cancer at the local level and, thus, contribute to the development of actions to control and prevent this disease.